Prostate Health
From Risk To Diagnosis
Before You Book
The prostate plays an important role in urinary and reproductive health, and conditions such as enlargement, inflammation, and prostate cancer become more common with age. Prostate cancer is one of the most common cancers in men, and while often slow‑growing, early detection can make a significant difference in treatment options and outcomes. Which is why understanding your risk and knowing your testing options matters.
Prostate Symptoms
-
Needing to pee more often, especially at night
-
Urgency or difficulty starting, weak flow or dribbling or Feeling the bladder doesn’t empty fully
-
Pain or burning when urinating
-
Blood in urine or semen
-
Pelvic, hip, or lower‑back pain
-
Sexual symptoms such as erectile difficulties or painful ejaculation
-
Many prostate conditions — including early prostate cancer — can cause no symptoms at all.
PSA Testing Limitations
-
PSA can rise due to benign causes such as infection or inflammation
-
A raised PSA does not always mean cancer
-
Some prostate cancers do not raise PSA levels
​
Getting the Most Accurate PSA Result
-
Avoid ejaculation for 48 hours before the test
-
Avoid vigorous exercise, especially cycling, for 48 hours
-
Rebook if you have a urinary infection or fever
-
Tell your clinician about medications that affect PSA
-
Avoid PSA testing soon after prostate procedures, including anal penetration, rectal examinations, catheterisation, cystoscopy, or biopsy, as these can temporarily raise PSA
You don’t need a prostate examination to have PSA blood tests. However, if you’d like to discuss symptoms or would benefit from an examination, this can be offered during a consultation.

PSA TEST- £84
A PSA test is a blood test that measures the level of prostate‑specific antigen (PSA), a protein made by both normal and cancerous prostate cells. It’s used to help check for prostate conditions, including prostate cancer, an enlarged prostate, or inflammation.
​​​
​
​
PMG Advanced Prostate Cancer Risk Test- £119
​
At Pembrokeshire Medical Group (PMG), we offer the PMG Advanced Prostate Cancer Risk Test, an innovative blood test designed to provide a more accurate assessment of prostate cancer risk than a standard PSA test alone.
Rather than relying solely on PSA levels, this advanced profile analyses a combination of clinically validated biomarkers to generate a personalised Prostate Cancer Risk Score, helping to identify men at higher risk while reducing unnecessary worry and investigations for those at lower risk.
Many men with early prostate cancer experience no symptoms at all, making proactive screening an important part of maintaining long-term health.
​
What's Included?
✅ Total Prostate Specific Antigen (PSA)
✅ Interleukin-8 (IL-8)
✅ Monocyte Chemotactic Protein-1 (MCP-1)
✅ Epidermal Growth Factor (EGF)
✅ Personalised Prostate Cancer Risk Score
​
Why Choose This Test?
-
More advanced than a standard PSA test alone
-
Provides a personalised assessment of prostate cancer risk
-
Helps identify higher-risk individuals earlier
-
Supports informed decisions about further investigation
-
May reduce unnecessary referrals and invasive procedures
-
Offers greater reassurance for men at lower risk
Advanced Screening
Episwitch PSE Testing
NOW AVAILABLE
£825
Our Epigenetics PSE screen analyses epigenetic markers associated with prostate cancer risk, providing a more precise than PSA testing. It identifies patients needing further investigation and minimises unnecessary tests for those at lower risk, offering a modern approach to prostate health in primary care.
​
*A PSA Level must but undertaken or known first
** May be covered by BUPA funding


Genetic Risk
£576
This test screens for genetic variants in 14 genes that may increase the risk of prostate cancer.
When to consider:
-
If you have already been diagnosed with prostate cancer and want to help tailor treatment or assess family risk
-
If you have a family history of prostate cancer
-
If you have Ashkenazi Jewish ancestry, where certain variants are more common
_edited.jpg)